EC-NAPROSYN

This brand name is authorized in United Kingdom, United States

Active ingredients

The drug EC-NAPROSYN contains one active pharmaceutical ingredient (API):

1 Naproxen UNII 57Y76R9ATQ - NAPROXEN

Naproxen is a non-steroidal anti-inflammatory analgesic compound with antipyretic properties as has been demonstrated in classical animal test systems. Naproxen exhibits its anti-inflammatory effect even in adrenalectomised animals, indicating that its action is not mediated through the pituitary-adrenal axis. Read about Naproxen

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NAPROSYN, EC-NAPROSYN, ANAPROX DS Tablet, Delayed-release tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M01AE02	Naproxen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 18474, 18493, 18521
Country: US	FDA, National Drug Code	Identifier(s): 69437-415, 69437-416